EUVIMEDDescoperă EUVIMED
Randomisierte kontrollierte StudieStudienprotokollOpen access

Effectiveness of a Person-Centered and Culturally Sensitive Course of Treatment in Arabic-, Turkish-, and Urdu-Speaking Individuals With Type 2 Diabetes (the ACCT2 Study): Protocol for a Pragmatic Randomized Controlled Trial

Wirksamkeit einer personenzentrierten und kultursensitiven Behandlung bei arabisch-, türkisch- und urdusprachigen Menschen mit Typ-2-Diabetes (ACCT2-Studie): Protokoll einer pragmatischen randomisierten kontrollierten Studie

Natasja Bjerre iD, Lene Christensen iD, Christina Hoeiberg iD, Cecilie Ottosson iD, Mie Klarskov Jensen iD, Nanna Kildsig iD, Trine Kjeldgaard Møller iD, Anne-Ditte Termannsen iD, Bettina Ewers iD, Britt Hollender-Schou iD, Rikke Molin Grue iD, Ulla Bjerre-Christensen iD and 2 more

JMIR Research Protocols · 2025-06-05 · 14 · e67319

DOI: 10.2196/67319 ↗

Auf einen Blick

Die ACCT2-Studie prüft eine 1-jährige personenzentrierte, kultursensitive Behandlung bei Menschen mit Typ-2-Diabetes. Primärer Endpunkt ist HbA1c.

Fragestellung

Welchen Effekt hat eine 1-jährige personenzentrierte und kultursensitive Intervention auf die glykämische Kontrolle bei arabisch-, türkisch- oder urdusprachigen Menschen mit Typ-2-Diabetes?

Methode

2-armige randomisierte kontrollierte Studie in Dänemark; 96 Erwachsene mit T2D und HbA1c ≥53 mmol/mol; 1:1-Randomisierung zu Intervention oder üblicher Versorgung; Messungen zu Baseline und nach 1 Jahr.

Ergebnisse

Primärer Endpunkt ist HbA1c. Sekundär werden Lipide, Blutdruck sowie patientenberichtete Outcomes, darunter Wohlbefinden, Diabetesmanagement, Gesundheitskompetenz und Medikamentennutzung, erhoben. 88 Teilnehmende waren im Januar 2025 rekrutiert.

Schlussfolgerung der Autor:innen

Die Studie soll Erkenntnisse zu personenzentrierten und kultursensitiven Behandlungsansätzen bei arabisch-, türkisch- oder urdusprachigen Menschen mit T2D liefern. Sie soll auch Einblicke in Erfahrungen, Hindernisse und Umsetzungsstrategien in Ambulanzen geben.

Kernaussagen

  • Pragmatische RCT mit 96 Erwachsenen mit T2D
  • Primärer Endpunkt: HbA1c nach 1 Jahr
  • Sekundär: Wohlbefinden, Diabetesmanagement und Gesundheitskompetenz

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

At a glance

Randomisierte kontrollierte Studie in JMIR Research Protocols, published online on 2025-06-05. Written by Natasja Bjerre and 13 co-authors. Institution: Department of Education, Steno Diabetes Center Copenhagen, Copenhagen University Hospital, Herlev, Denmark. Major MEDLINE topics: Culturally Competent Care, Diabetes Mellitus, Type 2. Cited 2 times so far (Crossref); 46 references. The full text is freely available in PubMed Central.

Auf einen BlickRezumatSubjectsDate bibliograficeCiteRelated studies

Abstract (original language)

Background

Individuals with non-Western backgrounds consistently exhibit a higher risk of type 2 diabetes (T2D) than ethnic Danes. Factors such as health behaviors, limited health care access, and social determinants of health often contribute to this disparity. Culturally sensitive interventions are crucial; however, effective interventions for managing T2D in non-Western populations remain limited.

Objective

This study aims to examine the effect of a 1-year person-centered and culturally sensitive intervention on improving glycemic control (hemoglobin A1c [HbA1c]) in Arabic-, Turkish-, or Urdu-speaking individuals with T2D. The secondary objectives are to improve diabetes management and overall well-being.

Methods

This study is designed as a 2-arm randomized controlled trial. A total of 96 women and men with T2D (HbA1c≥53 mmol/mol) speaking either Arabic, Turkish, or Urdu as their native language will be randomized for 1 year to a health care professional–assisted intervention group (person-centered and culturally sensitive course of treatment) or a control group (usual care) in a 1:1 ratio in Denmark. Assessments are scheduled at baseline and 1 year. The primary outcome is HbA1c, while lipids, blood pressure, and patient-reported outcomes, including well-being, diabetes management, health literacy, and use of and adherence to diabetes medication, are secondary outcomes. Feasibility and satisfaction are evaluated through interviews. The study is approved by the Ethics Committee of the Capital Region of Denmark (H-23042245).

Results

A 5.0-mmol/mol change in HbA1c is the minimally important difference, requiring 88 participants. To allow for uncertainties and dropouts, the total was increased to 96. As of January 2025, a total of 88 participants have been recruited. Recruitment was completed in March 2025. Data collection will continue until December 2025, with the first results expected by March 2026.

Conclusions

This study will contribute to the limited knowledge regarding the effects of person-centered and culturally sensitive treatment approaches for T2D in Arabic-, Turkish-, or Urdu-speaking individuals. The study uses a robust methodological design and will present an alternative avenue for managing T2D and improving overall well-being. The study offers valuable insights into the experiences of participants and health care professionals, including potential obstacles and strategies for implementation in outpatient clinics. Trial Registration ClinicalTrials.gov NCT06147245; https://clinicaltrials.gov/study/NCT06147245 International Registered Report Identifier (IRRID) DERR1-10.2196/67319

Subjects

MeSH terms (MEDLINE)

Culturally Competent CareDiabetes Mellitus, Type 2AdultFemaleHumansMaleMiddle AgedDenmarkGlycated HemoglobinLanguagePatient-Centered CareRandomized Controlled Trials as TopicTurkeyPragmatic Clinical Trials as Topic

Author keywords

culturally-sensitivediabetes managementethnic minoritiesimmigrantsmigrantspublic healthrandomized controlled trialtrialtype 2 diabeteswell-being

Substances

Glycated Hemoglobinhemoglobin A1c protein, human

Authors and institutions

  • Department of Education, Steno Diabetes Center Copenhagen, Copenhagen University Hospital, Herlev, Denmark.
  • Centre for Diabetes, Municipality of Copenhagen, Copenhagen, Denmark.
  • Department of Diabetes Treatment, Steno Diabetes Center Copenhagen, Copenhagen University Hospital, Herlev, Denmark.

ORCID profiles: Natasja Bjerre, Lene Christensen, Christina Hoeiberg, Cecilie Ottosson, Mie Klarskov Jensen, Nanna Kildsig, Trine Kjeldgaard Møller, Anne-Ditte Termannsen, Bettina Ewers, Britt Hollender-Schou, Rikke Molin Grue, Ulla Bjerre-Christensen, Solveig Jansen, Kamran Akram

Cite

APA

Bjerre, N., Christensen, L., Hoeiberg, C., Ottosson, C., Jensen, M. K., Kildsig, N., Møller, T. K., Termannsen, A. D., Ewers, B., Hollender-Schou, B., Grue, R. M., Bjerre-Christensen, U., Jansen, S., & Akram, K. (2025). Effectiveness of a Person-Centered and Culturally Sensitive Course of Treatment in Arabic-, Turkish-, and Urdu-Speaking Individuals With Type 2 Diabetes (the ACCT2 Study): Protocol for a Pragmatic Randomized Controlled Trial. JMIR Research Protocols, 14, e67319. https://doi.org/10.2196/67319

Vancouver

Bjerre N, Christensen L, Hoeiberg C, Ottosson C, Jensen MK, Kildsig N, et al. Effectiveness of a Person-Centered and Culturally Sensitive Course of Treatment in Arabic-, Turkish-, and Urdu-Speaking Individuals With Type 2 Diabetes (the ACCT2 Study): Protocol for a Pragmatic Randomized Controlled Trial. JMIR Research Protocols. 2025;14:e67319. doi:10.2196/67319

BibTeX
@article{Bjerre2025,
  author = {Bjerre, Natasja and Christensen, Lene and Hoeiberg, Christina and Ottosson, Cecilie and Jensen, Mie Klarskov and Kildsig, Nanna and Møller, Trine Kjeldgaard and Termannsen, Anne-Ditte and Ewers, Bettina and Hollender-Schou, Britt and Grue, Rikke Molin and Bjerre-Christensen, Ulla and Jansen, Solveig and Akram, Kamran},
  title = {Effectiveness of a Person-Centered and Culturally Sensitive Course of Treatment in Arabic-, Turkish-, and Urdu-Speaking Individuals With Type 2 Diabetes (the ACCT2 Study): Protocol for a Pragmatic Randomized Controlled Trial},
  journal = {JMIR Research Protocols},
  year = {2025},
  volume = {14},
  pages = {e67319},
  doi = {10.2196/67319}
}
Start for free →